Perry Sternberg
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Perry J.
Sternberg currently works at Sydnexis, Inc., as Chief Executive Officer & Director from 2024, Harrow, Inc., as Lead Independent Director from 2022, and Surface Ophthalmics, Inc., as Director.
Mr. Sternberg also formerly worked at Corium LLC (Massachusetts), as President & Chief Executive Officer from 2019 to 2024, Corium Innovations, Inc., as Chief Executive Officer, Corium LLC, as President, Chief Executive Officer & Director, Shire Plc, as Head-Neuroscience Business Unit from 2013 to 2019, and Bausch & Lomb, Inc., as Vice President & General Manager.
Mr. Sternberg received his undergraduate degree in 1990 from The Pennsylvania State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HARROW, INC. -.--% | 21.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HARROW, INC. | Direktor/Vorstandsmitglied | 31.03.2022 |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Direktor/Vorstandsmitglied | - |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 05.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| CORIUM INTERNATIONAL INC | Vorstandsvorsitzender | 01.07.2024 |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract development and manufacturing organization | Vorstandsvorsitzender | 17.01.2023 |
| SHIRE | Corporate Officer/Principal | 01.01.2019 |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Corporate Officer/Principal | - |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/
Bausch & Lomb, Inc. /Miracle-Ear Hearing Aid Business/ Medical SpecialtiesHealth Technology Manufactures and markets hearing aids and related products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corium International, Inc.
Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Harrow, Inc.
Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Surface Ophthalmics, Inc.
Surface Ophthalmics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on development and commercialization of therapeutics | Health Technology |
Corium Pharma Solutions, Inc.
Corium Pharma Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a contract development and manufacturing organization | Commercial Services |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen